Accelr8 Announces New Management
News Jun 29, 2012
Accelr8 Technology Corporation has announced the appointment of Lawrence Mehren as President and Chief Executive Officer and a member of the Board of Directors.
Most recently, Mr. Mehren was Head of Global Business of Ventana Medical Systems and Roche Tissue Diagnostics, managing its four business units, as well as Spring Biosciences, and mtm laboratories.
From 2007 until 2010 he held various global leadership positions with Ventana including Senior Vice President, Emerging Businesses, and Chief Financial Officer.
Previously, he was Managing Director, Partner and head of P&M Corporate Finance’s life sciences practice.
Prior to his tenure at P&M, Mr. Mehren worked in management positions with Gale Group, a division of The Thomson Corporation, as well as Merrill Lynch.
Mr. Mehren holds a B.A. from the University of Arizona and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management.
“We are fortunate to have someone of Larry Mehren’s caliber and experience to lead Accelr8” said John Patience, Chairman of the Board.
Patience continued, “Larry’s vision and proven track record of execution in the global diagnostics industry will allow us to fully realize the potential of Accelr8.”
“I am excited to be joining Accelr8 at such a pivotal time,” said Mehren.
“The company has created a unique solution to a tremendous unmet need. I look forward to advancing the development and commercialization of this transformational technology.”
Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast CancerNews
A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer.READ MORE
Researchers Discover Key Link Between Mitochondria and Cocaine AddictionNews
Researchers were able to block response in mitochondria to cocaine.READ MORE
Fraunhofer and Mologic Partner on Point-of-Care Diagnosis and Antibiotic Susceptibility Test for UTIsNews
Test will allow better targeting of prescription antibiotics and address growing antimicrobial resistance.READ MORE